Jonathan Yingling
Chief Tech/Sci/R&D Officer at ARCUS BIOSCIENCES, INC.
Network origin in Jonathan Yingling first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 47 | |
| Public Company | Biotechnology | 30 | |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.
16
| Extinct | Biotechnology | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jonathan Yingling via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer President Director/Board Member Chief Tech/Sci/R&D Officer | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Compliance Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| University of Virginia | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Comptroller/Controller/Auditor | |
| MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Director/Board Member Chairman Director/Board Member | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO | |
| ACERAGEN, INC. | Biotechnology | Chairman Director/Board Member General Counsel | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| BIOHAVEN LTD. | Pharmaceuticals: Major | Compliance Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder Founder Founder | |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Biotechnology | Chairman Director/Board Member | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Washington University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Chief Tech/Sci/R&D Officer | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Human Resources Officer | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Santa Clara University | College/University | Undergraduate Degree Undergraduate Degree | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin |
Statistics
International
| United States | 44 |
| Sweden | 2 |
| Denmark | 2 |
| United Kingdom | 2 |
| France | 2 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 352 |
| Corporate Officer/Principal | 220 |
| Independent Dir/Board Member | 141 |
| Chief Tech/Sci/R&D Officer | 80 |
| Undergraduate Degree | 72 |
Most connected contacts
| Insiders | |
|---|---|
| Dinesh C. Paliwal | 31 |
| Clarence Machado | 30 |
| Kathryn Falberg | 30 |
| Howard H. Pien | 27 |
| James Cornelius | 23 |
| Cristina Csimma | 21 |
| Thomas Lynch | 20 |
| Julian Baker | 20 |
| Charles Sigal | 20 |
| Brian Daniels | 20 |
| Terry Rosen | 19 |
| Michael Dougherty | 18 |
| Jennifer Jarrett | 18 |
| Lena Elisabeth Svanberg | 16 |
| Juan Jaen | 16 |
- Stock Market
- Insiders
- Jonathan Yingling
- Company connections
